Idexx Laboratories
IDXX • NASDAQ
Idexx Laboratories is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Jonathan J. Mazelsky, with a market cap of $48.4B.
CEOJonathan J. Mazelsky
Market Cap$48.4B
Medical - Diagnostics & Research
Healthcare
Employees11.0K
Websiteidexx.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Idexx Laboratories
Date
Thursday, April 30, 2026 (in 2 months)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$3.44
Revenue Estimate
$1.1B
Earnings History
Past 12 earnings reports for Idexx Laboratories
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 2, 2026 | Q4 2025 | $3.08Est: $2.93 | +5.1% | $1.1BEst: $1.1B | +1.8% |  10-K |
| Nov 3, 2025 | Q3 2025 | $3.22Est: $3.14 | +2.5% | $1.1BEst: $1.1B | +3.2% | 10-Q |
| Aug 4, 2025 | Q2 2025 | $3.50Est: $3.30 | +6.1% | $1.1BEst: $1.1B | +3.8% | 10-Q |
| May 1, 2025 | Q1 2025 | $2.91Est: $2.85 | +2.1% | $998.4MEst: $998.2M | +0.0% | 10-Q |
| Feb 3, 2025 | Q4 2024 | $2.53Est: $2.40 | +5.4% | $954.3MEst: $936.7M | +1.9% | 10-K |
| Oct 31, 2024 | Q3 2024 | $2.79Est: $2.68 | +4.1% | $975.5MEst: $979.2M | -0.4% | 10-Q |
| Aug 6, 2024 | Q2 2024 | $3.02Est: $2.87 | +5.2% | $1.0BEst: $1.0B | +0.4% | 10-Q |
| May 1, 2024 | Q1 2024 | $2.81Est: $2.67 | +5.2% | $964.1MEst: $967.2M | -0.3% | 10-Q |
| Feb 5, 2024 | Q4 2023 | $2.32Est: $2.12 | +9.4% | $901.6MEst: $891.2M | +1.2% | 10-K |
| Nov 1, 2023 | Q3 2023 | $2.53Est: $2.37 | +6.8% | $915.5MEst: $926.8M | -1.2% | — |
| Aug 1, 2023 | Q2 2023 | $2.67Est: $2.43 | +9.9% | $943.6MEst: $927.8M | +1.7% | 10-Q |
| May 2, 2023 | Q1 2023 | $2.55Est: $2.42 | +5.4% | $900.2MEst: $892.9M | +0.8% | — |